Healthcare - Biotechnology - NASDAQ - US
$ 13.86
-9.41 %
$ 807 M
Market Cap
-5.39
P/E
BALANCE SHEET
484 M
ASSETS
30.3 M
LIABILITIES
454 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Cullinan Oncology, Inc.
| Current Assets | 480 M |
| Cash & Short-Term Investments | 467 M |
| Receivables | 0 |
| Other Current Assets | 13.1 M |
| Non-Current Assets | 3.99 M |
| Long-Term Investments | 0 |
| PP&E | 3.53 M |
| Other Non-Current Assets | 459 K |
| Current Liabilities | 28.1 M |
| Accounts Payable | 2.49 M |
| Short-Term Debt | 2.88 M |
| Other Current Liabilities | 22.8 M |
| Non-Current Liabilities | 2.15 M |
| Long-Term Debt | 2.15 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 98.4 | 550.1 | 430.9 | 168.2 | 63.2 | 33.8 |
| Short Term Investments | 368.6 | 311.1 | 230.7 | 42.0 | 35.4 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 13.1 | 7.2 | 12.2 | 4.1 | 1.5 | 0.4 |
| Total Current Assets | 480.2 | 474.5 | 296.6 | 212.3 | 100.1 | 34.2 |
| PP&E | 3.5 | 5.3 | 77 K | 0.1 | 0.2 | 0.2 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 80.9 | 140.4 | 0 | 0 | 0 |
| Other Long Term Assets | 0.5 | 0.5 | 0.1 | 2.3 | 0.2 | 0.2 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 484.2 | 561.1 | 437.2 | 214.7 | 100.5 | 34.6 |
| LIABILITIES | ||||||
| Accounts Payable | 2.5 | 2.7 | 3.2 | 9.7 | 0.9 | 0.3 |
| Short Term Debt | 2.9 | 1.6 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 22.8 | 14.0 | 8.6 | 4.6 | 1.6 | 1.0 |
| Total Current Liabilities | 28.1 | 22.5 | 11.7 | 14.3 | 2.5 | 1.3 |
| Long Term Debt | 2.1 | 3.6 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 65 K | 74 K | 137.8 | 54.0 |
| Total Liabilities | 30.3 | 26.1 | 11.8 | 291.0 | 140.4 | 55.3 |
| EQUITY | ||||||
| Common Stock | 4 K | 5 K | 4 K | 1 K | 1 K | 1 K |
| Retained Earnings | (200.9) | (47.7) | (158.9) | (93.3) | (41.5) | (20.9) |
| Other Accumulative Comprehensive Income/Loss | (0.1) | (2.6) | (0.8) | 2 K | 4 K | 1 K |
| Total Equity | 453.9 | 535.0 | 423.0 | (76.3) | (39.9) | (20.6) |
| Total Liabilities and Equity | 484.2 | 561.1 | 434.8 | 214.7 | 100.5 | 34.6 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 41.5 | 45.2 | 44.3 | 43.5 | 43.5 | 11.4 |